Petros Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PTPI
CUSIP
71678J209
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 71678J209 since 12/18/2024, newest first.

Filer % of Class Filed
Iroquois Capital Management, LLC 13G/A Amendment 1
10.0% 5/15/2025
Event 3/31/2025
Iroquois Capital Management, LLC 13G
10.0% 2/26/2025
Event 2/17/2025
Ayrton Capital LLC 13G/A Amendment 2
6.2% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q1 16 1.13 M $77.6 k
2024 Q4 10 97.7 k $38.5 k
2024 Q3 12 166 k $59.2 k
2024 Q2 14 208 k $94.9 k
2024 Q1 16 65.3 k $96.4 k
2023 Q4 18 117 k $165 k
2023 Q3 15 99.6 k $171 k
2023 Q2 15 102 k $214 k
2023 Q1 11 30.8 k $42.7 k
2022 Q4 12 39.1 k $90.6 k